Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study
Miriam A. Schiele, Peter Zwanzger, Kathrin Schwarte, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 3, pp. 191-199
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Neuroinflammatory Basis of Depression: Learning From Experimental Models
Ruqayya Afridi, Kyoungho Suk
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 57
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders
Yousef Rasmi, Ameneh Shokati, Amber Hassan, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 28-37
Open Access | Times Cited: 49
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljević, Dubravka Švob Štrac, Jasna Jančić, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 22
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry
Dhoha Dhieb, Kholoud Bastaki
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1082-1082
Open Access | Times Cited: 1
The associations between DNA methylation and depression: A systematic review and meta-analysis
Jiahui Zhu, Hao-Hui Bo, Bao-Peng Liu, et al.
Journal of Affective Disorders (2023) Vol. 327, pp. 439-450
Closed Access | Times Cited: 21
Summer and SERT: Effect of daily sunshine hours on SLC6A4 promoter methylation in seasonal affective disorder
Patricia Handschuh, Matej Murgaš, Dietmar Winkler, et al.
The World Journal of Biological Psychiatry (2025), pp. 1-11
Open Access
Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters
Sarah Nazzari, Serena Grumi, Fabiana Mambretti, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder
Piotr Czarny, Katarzyna Białek, Sylwia Ziółkowska, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 167-167
Open Access | Times Cited: 26
Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach
V. Sreeja, Anju Jose, Shashikant Patel, et al.
Neurochemistry International (2023) Vol. 173, pp. 105672-105672
Closed Access | Times Cited: 9
No association between peripheral serotonin-gene-related DNA methylation and brain serotonin neurotransmission in the healthy and depressed state
S.E.P. Bruzzone, B. Ozenne, Patrick M. Fisher, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives
Muqtada Shaikh, Gaurav Doshi
European Journal of Pharmacology (2024) Vol. 978, pp. 176757-176757
Closed Access | Times Cited: 3
DNA methylation in stress and depression: from biomarker to therapeutics
Amanda J. Sales, Francisco Silveira Guimarães, Sâmia R.L. Joca
Acta Neuropsychiatrica (2021) Vol. 33, Iss. 5, pp. 217-241
Closed Access | Times Cited: 19
Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review
Jan Dahrendorff, Glenn W. Currier, Monica Uddin
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2024) Vol. 195, Iss. 7
Open Access | Times Cited: 2
Personalized Medicine in Psychiatry
Giampaolo Perna, Alessandra Alciati, Charles B. Nemeroff
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 2
Hypermethylation of the serotonin transporter gene and paternal parenting styles in untreated anorexia nervosa patients: A pilot study
Qianqian He, Cheng Lian, Sufang Peng, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e12635-e12635
Open Access | Times Cited: 5
Can Epigenetics Predict Drug Efficiency in Mental Disorders?
Gil Ben David, Yam Amir, Randa Salalha, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 5
Evaluation of DNA methylation in BDNF , SLC6A4 , NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder
Saeid Mohammadi, Abbas Beh-Pajooh, Mahnaz Ahmadimanesh, et al.
Epigenomics (2022) Vol. 14, Iss. 20, pp. 1269-1280
Closed Access | Times Cited: 8
ABSP: an automated R tool to efficiently analyze region-specific CpG methylation from bisulfite sequencing PCR
Marie Denoulet, Mathilde Brulé, François Anquez, et al.
Bioinformatics (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Deep phenotyping as a contribution to personalized depression therapy: the GEParD and DaCFail protocols
Katharina Lichter, Catherina Klüpfel, Saskia Stonawski, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 707-722
Open Access | Times Cited: 4
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
Miriam A. Schiele, Andreas Reif, Jiaxi Lin, et al.
European Neuropsychopharmacology (2021) Vol. 44, pp. 105-120
Open Access | Times Cited: 9
Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments
Eric J. Lenze, John Torous, Patricia A. Areán
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 205-214
Closed Access | Times Cited: 3
Combination of spontaneous regional brain activity and HTR1A/1B DNA methylation to predict early responses to antidepressant treatments in MDD
Chenjie Gao, Zhi Xu, Tingting Tan, et al.
Journal of Affective Disorders (2022) Vol. 302, pp. 249-257
Closed Access | Times Cited: 5
DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Laura Musazzi, Caterina Paoli, Paulina Misztak, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 12, pp. 2267-2291
Open Access | Times Cited: 5
Precision Medicine in Antidepressants Treatment
Evangelia Eirini Tsermpini, Alessandro Serretti, Vita Dolžan
Handbook of experimental pharmacology (2023), pp. 131-186
Closed Access | Times Cited: 2
DNA methylation of serotonin genes as predictive biomarkers of antidepressant treatment response
S.E.P. Bruzzone, Brice Ozenne, Patrick M. Fisher, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024), pp. 111160-111160
Open Access
Page 1 - Next Page

Scroll to top